Samsung Biologics Expands South Korean Footprint
Samsung Biologics Expands South Korean Footprint
KOFU, JAPAN--May 23, 2023--Researched by Industrial Info Resources (Sugar Land, Texas)--Samsung Biologics (Incheon, South Korea) will begin work on a second biocampus in South Korea with the construction of "Plant 5," which will be built in Songdo District 11, Incheon.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Indiana Home to $28 Billion in Manufacturing Projects
- Rising Demand for Propylene Spurs Investments in Propane Dehydrogenation Un...
- Three Largest Refineries Set for Startup in 2024 Face Delays
- Report: U.S. Solar Market Sizzled in 2023, Further Strong Growth Expected
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
